Estimates Revisions DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Shanghai S.E.
09/10/2026
|
5-day change | 1st Jan Change | ||
| 18.76 CNY | +2.18% |
|
+3.08% | +6.47% |
| 11:52am | DaShenLin Pharmaceutical to Pay H1 Dividend on Oct. 19 | MT |
| 09-02 | Jefferies Adjusts DaShenLin Pharmaceutical Group's Price Target to 15 Yuan From 12 Yuan, Keeps at Underperform | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 603233 Stock
- Consensus DaShenLin Pharmaceutical Group Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
